BioCardia (BCDA) Enterprise Value (2015 - 2026)

BioCardia (BCDA) has reported Enterprise Value for 12 consecutive years, with $10.9 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Enterprise Value rose 11.53% year-over-year to $10.9 million in Q2 2026; TTM through Jun 2026 was $10.9 million, a 11.53% increase from a year earlier, with the FY2025 full-year figure at $5.8 million, up 61.68% from the prior year.
• Enterprise Value was $10.9 million for Q2 2026 at BioCardia, down from $12.3 million in the prior quarter.
• Over five years, Enterprise Value peaked at $53.3 million in Q2 2023 and troughed at $2.8 million in Q3 2025.
• A 5-year average of $16.3 million and a median of $10.9 million in 2025 frame the typical range for Enterprise Value.
• Across the five-year window, Enterprise Value soared 211.22% in 2023 and tumbled 90.84% in 2024, its largest moves.
• Over 5 years, Enterprise Value stood at $34.6 million in 2022, then sank by 58.04% to $14.5 million in 2023, then sank by 75.13% to $3.6 million in 2024, then soared by 61.68% to $5.8 million in 2025, then surged by 86.35% to $10.9 million in 2026.
• The last three Enterprise Value figures came in at $10.9 million (Q2 2026), $12.3 million (Q1 2026), and $5.8 million (Q4 2025), per Business Quant data.